T1	Participants 64 84	children with autism
T2	Participants 1106 1186	Thirty-three subjects (31 male subjects, 2 female subjects; aged 3.2-10.7 years)
T3	Participants 1217 1305	Follow-up data was available on 14 subjects in the NAC group and 15 in the placebo group
